Centiva Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-14,900
| Closed | -$45.3K | – | 1889 |
|
|
2024
Q4 | $45.3K | Sell |
14,900
-67,697
| -82% | -$206K | ﹤0.01% | 1198 |
|
|
2024
Q3 | $429K | Sell |
82,597
-58,662
| -42% | -$304K | 0.01% | 900 |
|
|
2024
Q2 | $363K | Buy |
141,259
+126,259
| +842% | +$324K | 0.01% | 945 |
|
|
2024
Q1 | $73.8K | Sell |
15,000
-10,885
| -42% | -$53.6K | ﹤0.01% | 1269 |
|
|
2023
Q4 | $228K | Sell |
25,885
-288,776
| -92% | -$2.54M | 0.01% | 903 |
|
|
2023
Q3 | $3.61M | Buy |
314,661
+274,661
| +687% | +$3.15M | 0.08% | 105 |
|
|
2023
Q2 | $1.01M | Buy |
40,000
+13,800
| +53% | +$349K | 0.02% | 324 |
|
|
2023
Q1 | $844K | Buy |
+26,200
| New | +$844K | 0.02% | 371 |
|